Научная статья на тему 'SYNTHESIS OF 4-HYDROXIBENZOIC ACID DERIVATIVES WITH AMINO ACIDS AND THEIR POTENTIAL PHARMACOLOGICAL PROPERTIES'

SYNTHESIS OF 4-HYDROXIBENZOIC ACID DERIVATIVES WITH AMINO ACIDS AND THEIR POTENTIAL PHARMACOLOGICAL PROPERTIES Текст научной статьи по специальности «Фундаментальная медицина»

CC BY
179
62
i Надоели баннеры? Вы всегда можете отключить рекламу.
Ключевые слова
4-HYDROXYBENZOIC ACID / GLYCINE / 4-AMINOBUTANOIC ACID / SALT / SYNTHESIS / BIOLOGICAL ACTIVITY
i Надоели баннеры? Вы всегда можете отключить рекламу.
iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.
i Надоели баннеры? Вы всегда можете отключить рекламу.

Текст научной работы на тему «SYNTHESIS OF 4-HYDROXIBENZOIC ACID DERIVATIVES WITH AMINO ACIDS AND THEIR POTENTIAL PHARMACOLOGICAL PROPERTIES»

https://doi.org/10.29013/AJT-22-1.2-24-27

Bakhramov Khasan Kayumovich, Bukhara State Medical Institute, assistant, Medical Chemistry Department Niyazov Laziz Nurkhonovich, Bukhara State Medical Institute, Head of Department, Medical Chemistry Department

SYNTHESIS OF 4-HYDROXIBENZOIC ACID DERIVATIVES WITH AMINO ACIDS AND THEIR POTENTIAL PHARMACOLOGICAL PROPERTIES

Abstract. Derivatives of 4-hydroxybenzoic acid with glycine and 4-aminobutanoic acid have been synthesized. To increase the solubility of substances, salts with potassium were poured. It is shown that the synthesized substances have biological activity. Synthesized substances were studied using computer programs Gausview, Passonline, which showed the activity of molecules and biological activity. Experiments will be conducted to confirm the activity.

Keywords: 4-hydroxybenzoic acid, glycine, 4-aminobutanoic acid, salt, synthesis, biological activity.

Introduction plant called Spirae Ulmaria. In this case, the letter

Today, the synthesis of drugs is one of the cur- "a" (acylation) was added before the word "spir" rent problems of chemistry. Since the middle of the and then the suffix "in" was added to make it sound

19th century, salicylic acid (SA) has been isolated from salicin. Aspirin was developed and patented by Bayer specialists during the synthesis of its compounds in order to study the biologically active properties of SA. Although aspirin was synthesized and used for over 150 years, it is still used as one of the most widely used pharmacological drugs in the world. Acetylsalicylic acid (ASA) has specific biological properties (anti-inflammatory, antipyretic, antithrombotic, analgesic). In the body ASA inhibits cyclooxygenase and irreversibly inhibits the metabolic pathway of cyclooxygenase (COX-1 and COX-2) of arachidonic acid, i.e. it stops the synthesis of several prostaglandins [1]. Usually the origin of the term aspirin is associated with hyperthermic properties, from the ancient Greek "pyro" -fire. However, there is another idea, namely, that salicylic acid was first isolated by C. Lovig from a

better [2]. According to recent data, SA products are synthesized in the body and act as a bioregulator and have a protective function, which, in turn, means that the role of SA in human and animal pathophysiology should be reviewed [3; 4].

In this regard, one of the urgent tasks is the synthesis of new substances and their derivatives based on oxybenzoic acids, creation of new methods of synthesis and development of existing ones. It is also important to target therapeutic agents based on oxybenzoic acids with low toxic properties and high biologically active properties.

Materials and Methods

It is known that SA derivatives are obtained by different methods, one of which is the production of esters, i.e., alkyl ethers, carried out in the presence of catalytic sulfuric acid with the corresponding alcohols:

The duration of the esterification reaction according to the classical method is 5-12 hours, and the yield of the reaction is from 55% to 80%, depending on the ortho-, meta-, and para-states of the -OH and -COOH groups, as well as the molecular weight of the alcohol [5; 6].

However, another way to obtain esters is the application of silver and sodium salts to halogen derivatives, for example, the interaction of sodium salicylate and benzyl chloride produces benzylsalicylate. In this reaction dimethylformamide 1100C the yield was 79% when conducted in the environment [7; 8].

OH

,COONa

CH2Cl

rl

OH

DMFA

110oC

NaCl

SA amides and its derivatives has a variety of pharmacological activities: antipyretic, sedative, anti-vibration, and high diaphoretic activity [7; 8].

Therefore, intermediate derivatives of SA are very important because they facilitate the synthesis of substances of a given composition. In our opinion, carbonic acid chlorohydride is an intermediate for the synthesis of the corresponding amides because

it forms an amide corresponding to ammonia. The reaction requires a lot of ammonia and additionally hydrochloric acid. In general, the reaction scheme can be written as follows:

RC(O)Cl + 2NH3 RC(O)NH2 + NH4Cl However, amides are also obtained by the interaction of amines with chlorohydrides in the following reaction:

ÏÏSH2

R N

H

R2TMH

J.

Synthesis of preservative derivatives of SA nitrogen compounds is a promising area of search for new effective and non-toxic long-acting drugs. The role of amino acids in the body is very broad; complex substances such as amino acids, peptides and proteins

are structural components of enzymes, coenzymes, hormones and receptors [9; 10]. Amine derivatives exhibit a variety of biological activities, including psychotropic, analgesic, anti-inflammatory and others. Today in practice there is increasing interest in

+

+

y-aminobutyric acid (GABA) and its derivatives, many drugs based on GABA have neuroprotective activity [11; 12].

Therefore, the synthesis of hydroxybenzoic acid derivatives with amino acids is relevant. For this purpose, a 4-hydroxybenzoic acid-based SA derivative was synthesized and their potassium salts were obtained to increase the water solubility of the synthesized substance.

o

II

h2n'

-cooh

ho'

Synthesis of N-(4-acetoxybenzoyl)glycine

A stirrer, reflux condenser and thermometer are placed in a three-neck flask.10.00 g (72.40 mmol) of 4-oxybenzoylglycine, 25.00 ml of acetic acid and 0.20 ml of sulfuric acid. To the 6.8 mL mixture was added (72.40 mmol) acetic anhydride and stirred at 45 °C for 2 hours. The precipitated crystals are recrystallized with isopropanol, filtered and dried. The yield is 73%. Tm = 194-197 °C.

Synthesis of 4-[(N-4-acetoxybenzoyl)amino] butanoic acid

N-(4-acetoxybenzoyl) is obtained as glycine. The yield of the reaction is 76%. Tm = 195-197 °C. Potassium salt ofN-(4-acetoxybenzoyl)glycine 4.6 g (100 mmol) of potassium ethylate (potassium metal treated with absolute ethanol), 100.00 g of benzene and 2.70 g (100 mmol) of N-(4-ace-toxybenzoyl)glycine in a three-neck flask with stirrer, reverse cooler and thermometer are added. The mixture in the flask is stirred at 100 °C for 30 minutes. After cooling the mixture is filtered, washed with a slightly alkaline alcohol solution and dried. The re-

Synthesis of N-(4-hydroxybenzoyl)glycine

The obtained 4-hydroxybenzoyl chloride is introduced dropwise for 1.5-2 h with a glycine solution (5.00 g g glycine in 28.30 ml water). The mixture is cooled, then stirred for another 1.5 hours, keeping the pH > 7. The resulting mixture is poured on ice. Hydrochloric acid is added to pH = 5. The resulting precipitate is filtered and dried. The yield is 76%. Tm = 220-223 °C.

-HCl

HO'

COOH

sulting substance is a white crystal. The yield is 72%. Tm = 203-205 °C.

Potassium salt of 4- [N-(4-acetoxybenzoyl) amino]butanoic acid

The yield of the reaction is 78%. Tm = 235 -- 237 °C. Conclusion

Some quantum-chemical properties of substances were studied. The results of the studies show complex interactions of functional groups in the molecules of substances. Based on the structure of the obtained substances, it can be concluded that they can form complex compounds. The structure of the obtained 4-hydroxybenzoic acid derivatives was confirmed by IR, H1NMR, C13NMR spectroscopy, the physical and chemical properties of compounds were studied [13; 14]. The PASS Online program was used to predict the biological activity of the synthesized substances. From the prediction follows the need for preclinical studies to confirm the pharmacological properties of the substances obtained [15; 16].

References:

1. Соловьев В. Г., Нехорошев С. В., Клименко Л. С., Леонов В. В., Слепченко Г. Б., Нехорошева Д. С. Биомедицинское значение салицина и его производных, перспективы дальнейших исследований // Научный медицинский вестник Югры.- № 4 (18). 2018.- С. 4-8.

+

2. Опимах И. В. Правда и миф об аспирине // Медицинские технологии. Оценка и выбор.- № 1. 2015.- С. 60-64.

3. Salicylic Asid sans Aspirin in Animals and Man: Persistence in Fasting and Biosynthesis from Benzoic Acid // J / R. Paterson [etal/] // J. Agric. Food Chem.- Vol. 56.- № . 24. 2008.- P. I1648-I1652.

4. Беккер Г. Органикум. Практикум по органической химии. В 2- т.,- Т. 2. / Г. Беккер.- М.: Мир, 1979.-448 c.

5. Титце Л. Препаративная органическая химия / Л. Титце, Т. Айхер.- М.: Мир, 1999.- 704 c.

6. Ниязов Л. Н., Брель А. К., Бахромов Ю. К. Салитцил кислота амиди тузининг аминобутан кислота билан синтези // Бухарский инженерно-технологический институт. Развитие науки и техники.-№ 5. 2020.- С. 44-46.

7. Niyazov L. N., Brel А. К., Bahromov H. Q. Salitsil kislota hosilasi, uning natriyli va kaliyli tuzlari sintezi hamda xossalari //Илмий хабарнома. Серия: Кимё тад^и^отлари.- №. 7 (51). 2020.- 28 c.

8. Бахрамов Х. К., Ниязов Л. Н. Синтез производных гидроксибензойных кислот и их антибактериальная активность // Журнал: Наманган Д. У Илмий ахборотнома - № 12. 2020.- 69 c.

9. Ниязов Л. Н., Бахромов Х. К., Гапуров У У Квантово-химическое исследование производных ги-дроксибензойной кислоты с аминокислотами // IV международная научная конференция молодых исследователей материалы. Секция 1.- Баку, Азербайджан. 2020.- 245 c.

10. Ниязов Л. Н., Брель А. К., Бахромов Х. К., Гапуров У У 4-гидроксибензой кислотанинг досилалари потенциал дори воситалари сифатида / Республиканской научно-практической конференции фармакологов с международным участием.- Бухара, Узбекистан. 2020.- 159 c.

11. Ниязов Л. Н., Брель А. К., Бахромов Х. К., Гапуров У. У. Квантово-химическое изучение N-[8-(4-ацетоксибензоил)амино]каприлата калия / Республиканской научно-практической конференции фармакологов с международным участием.- Бухара, Узбекистан.- 28-29 мая. 2020.- C. 160-161.

12. Ниязов Л. Н., Брель А. К., Бахромов Х. К., Гапуров У. У. Салициоилглициннинг дикалийли тузи досиласи синтези / Кимёнинг долзарб муаммолари. Республика илмий амалий анжуман.- Toshkent. 2021.- 269 c.

13. Ниязов Л. Н., Брель А. К., Бахромов Х. К., Соли салициловой кислоты с некоторыми d-металлами / II Международная онлайн научно-практическая конференция "Актуальные вопросы фармакологии: от разработки лекарственных средств до их рационального применения" сборник тезисов. - Бухара. 2021.- 152 c.

14. Ниязов Л. Н., Брель А. К., Бахромов Х. К., Гапуров У У, Каримов Ж. С. Синтез натриевой соли производного салициловой кислоты / Материалы международной научно-теоретической конференции по теме: "Куатбековские чтения-1: уроки независимости", посвященной 30-летию Независимости Республики Казахстан.- Шымкент. 2021.- 29 c.

15. Бахромов Ниязов Л. Н. Салицил кислота амидларининг баъзи d-металларбилан комплекслари / "Комплекс бикмалар кимёсининг долзарб муаммолари" мавзусидаги Республика илмий-амалий конференция материаллари туплами.- Тошкент. 2021.- 193 c.

16. Ниязов Л. Н., Брель А. К., Бахрамов Х. К. Соли салициловой кислоты с некоторыми d-металлами // II Международная онлайн научно-практическая конференция "Актуальные вопросы фармакологии: от разработки лекарственных средств до их рационального применения" сборник тезисов.-Бухара. 2021. (6-7 мая).- 152 c.

i Надоели баннеры? Вы всегда можете отключить рекламу.